All In Biotech

Drug Trial Radar · NCT00758641

Platelet Rich Plasma to Treat Plantar Fasciitis

Use of PRP to Treat Plantar Fasciitis, Blinded and Randomized as a Multi Center Study

Last checked: Nov 21, 2026Latest source record: Mar 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 115 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

115

Actual

Start

Sep 2009

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
Zimmer BiometIndustry
Sponsor type
Industry
Collaborators
Elisabeth-TweeSteden Ziekenhuis; Diaconessenhuis Leiden Netherlands; Biomet Nederland BV
First posted
Sep 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Rationale: The standard treatment of chronic plantar fasciitis is corticosteroid injections. Corticosteroid injection give temporarily pain reduction, but no healing. Blood platelets initiate the natural healing rate. GPS ® gives an eightfold concentrate platelets of patients own blood. Injection of these platelets in the tendon might induce a healing rate. Objective: To compare the efficacy of autologous platelet concentrate injections with corticosteroid injection in patients suffering from plantar fasciitis with respect to pain and function.

Conditions

  • Plantar Fasciitis

Interventions

  • L-PRP InjectionDevice

    L-PRP produced with Biomet Recover L-PRP Platelet Separation Kit

  • Corticosteroid InjectionDrug

    kenacort 40 mg/ml triamcinolon acetonide

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of successfully treated patientsTime frame: 6 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Haga ziekenhuis

    DenHaag, Netherlands

  • Albert Schweitzer Ziekenhuis

    Dordrecht, Netherlands

  • Diaconessehuis

    Leiden, Netherlands

  • Academisch Ziekenhuis Maastricht

    Maastricht, Netherlands

  • St Elisabeth Hospital

    Tilburg, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.